Clinical Trial Update: Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating image-guided biopsies to identify resistance mechanisms in patients with metastatic castration-resistant prostate cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Pluvicto (177Lu-PSMA-617) (lutetium-177 PSMA-617)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 1 | Status: RECRUITING